Source: Nine For News

video

California physician Brian Tyson successfully treated thousands of patients with hydroxychloroquine in his clinic. In the studio of One America News , he said he has now cured nearly 5,000 patients. Two patients died and six had to go to hospital. The doctor also warned that an experimental vaccine puts people at risk unnecessarily.

“Early treatment is key,” explained Dr. Tyson. It doesn’t matter how old people are. If we treat them early on, their condition will improve, he said.

The big problem, he says, is that people do not recognize that the treatment is working. Lives are thus endangered. “They don’t listen to what we say. They listen to people who are not caring for patients. “

1,500 deaths

We don’t need a vaccine against corona, Dr. Tyson stressed. He noted that there have been 1,500 reports of deaths related to the corona vaccine at VAERS, the US counterpart of Lareb. He said the corona vaccines have already caused more cases of side effects than all the other vaccines put together.

Tyson pointed out that people who die from the vaccine live an average of 79 years old. “So it’s probably not a good idea to give it to high-risk patients,” he said. The benefits don’t outweigh the risks.

For Dr. Tyson, many other doctors and patients, hydroxychloroquine is still the best solution.







Related: Act early with early Covid-19 treatment: Dr Vladimir Zelenko

COVID-19 outpatients – early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

The story behind hydroxychloroquine and the Zelenko Protocol: safe pre-hospital treatments for Covid

‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor

Low Dose Hydroxychloroquine is Associated with Lower Mortality in COVID-19: A Meta-Analysis of 27 Studies and 44,684 Patients

Top US medics recommend ‘sequenced multidrug therapy’ including HCQ & Ivermectin, for early high-risk COVID-19 infections

Epidemiologist At Yale Provides Testimony On Hydroxychloroquine For Treating COVID-19

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »